Study finds early treatment benefits for rheumatoid arthritis

A Norwegian study published in Annals of the Rheumatic Diseases indicates that starting treatment early for rheumatoid arthritis can lead to high remission rates after ten years. The research followed patients recently diagnosed with the condition and treated with methods designed to control the disease.

High remission rate after ten years

Among the 179 participants with usable data after a decade, 82% were in clinical remission. This was determined using a DAS score lower than 1.6, which evaluates painful or swollen joints, a blood marker for inflammation, and the patient's own assessment of their condition.

Focus on first two years of treatment

The study emphasizes the importance of the first two years in managing rheumatoid arthritis, a chronic condition that causes pain, joint swelling, and challenges in performing daily tasks. If inflammation is not adequately controlled, joints can suffer from long-term damage.

Treat-to-target strategy used

Doctors often use a method known as "treat-to-target," where treatments are adjusted until a specific goal is met, typically remission or low disease activity. This approach was part of the strategies used in the study to manage patients' conditions effectively.

Ultrasound monitoring not more effective

One of the strategies also used ultrasound to detect ongoing inflammation. However, this additional monitoring did not result in significantly better outcomes compared to standard treatment approaches. Researchers still found encouraging results in how joint damage progressed, as shown by X-ray evaluations.